Veropharm   Report issue

For profit Phase 3
Founded: Moscow Russian Federation (1997)
Status: Acquired by Abbott (2014)

Organization Overview

First Clinical Trial
2011
NCT01388738
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (3)

cenegermin-bkbj (oxervate) (1 trial)

citicoline (1 trial)

l-alpha-glycerophosphocholine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Stroke (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 3